A Houston-based compounding pharmacy that was recently roped into Eli Lilly’s fight against knockoff GLP-1s has landed in the FDA’s crosshairs for the second time in less than a year. | The FDA has ...

A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...

In 2022, the SURMOUNT-1 trial initially found that adults randomised to tirzepatide for 72 weeks lost on average 15% to 21% of their initial weight depending on the dose [1]. This new analysis ...

New data documented dramatic shifts in prescribing for both type 2 diabetes (T2D) and weight loss, particularly with the uptake of tirzepatide (Lilly) and declines in the use of older agents.

Novo Nordisk's stocks face YTD struggles due to trial results and tariffs, but strong fundamentals and outlook justify a Buy.

High-dose aflibercept offers extended dosing intervals for DME and wet AMD, with sustained visual and anatomical improvements. The PULSAR and PHOTON trials showed efficacy in maintaining vision ...

The prescribed dosage for dexamethasone may vary depending on a person’s individual treatment plan. Factors such as your medical history and body weight may also affect your dosage of dexamethasone.

Standard dosing algorithms could be responsible for the higher rates of thyrotoxicosis among older women vs men prescribed levoythroxine.

Improvement seen in nocturnal lung function and overnight suppression of blood eosinophil counts with a dosage time of between 3 through 4pm. HealthDay News — Midafternoon dosing with ...

But Novo Nordisk isn't alone. It soon was joined by Eli Lilly (NYSE: LLY), selling similar drugs -- the molecule tirzepatide, approved in 2022 under the name Mounjaro for the diabetes indication ...